NCT02900248View on ClinicalTrials.gov

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

TerminatedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
NeoplasmsLung NeoplasmsColon NeoplasmsBreast NeoplasmsPancreatic NeoplasmsProstate NeoplasmsKidney NeoplasmsLiver NeoplasmsRectal NeoplasmsHematologic NeoplasmsMultiple MyelomaMyelodysplastic SyndromesOvarian NeoplasmsBladder NeoplasmsTesticular NeoplasmsEndometrial NeoplasmsBrain NeoplasmsBiliary Tract NeoplasmsHead and Neck NeoplasmsUterine Cervical NeoplasmsSkin NeoplasmsMelanomaGastric NeoplasmsAnal NeoplasmsSarcoma
Interventions
OTHER

Provider determined

Provider will treat patient as he/she feels best

Trial Locations (1)

83404

Teton Cancer Institute, Idaho Falls

Sponsors

Lead Sponsor

CureOne
All Listed Sponsors
lead

CureOne

OTHER